Poolbeg Pharma Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Poolbeg Pharma.
Key information
-14.2%
Earnings growth rate
-3.4%
EPS growth rate
| Pharmaceuticals earnings growth | 15.5% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 30 Mar 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | N/A | -6 | -7 | -6 | 2 |
| 12/31/2023 | N/A | -6 | -6 | -6 | 2 |
| 12/31/2022 | N/A | -5 | -5 | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: POLB.F is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: POLB.F is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: POLB.F is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if POLB.F's revenue is forecast to grow faster than the US market.
High Growth Revenue: POLB.F is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if POLB.F's Return on Equity is forecast to be high in 3 years time